Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder

While double-blinding is a crucial aspect of study design in an interventional clinical trial of medication for a disorder with subjective endpoints such as major depressive disorder, psychotherapy clinical trials, particularly cognitive-behavioral therapy trials, cannot be double-blinded. This pape...

Descripción completa

Detalles Bibliográficos
Autor principal: Berger, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Clinical Practice Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732552/
https://www.ncbi.nlm.nih.gov/pubmed/26870318
http://dx.doi.org/10.12688/f1000research.6953.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732552/
https://www.ncbi.nlm.nih.gov/pubmed/26870318
http://dx.doi.org/10.12688/f1000research.6953.2

Ejemplares similares